Fingerprint
Dive into the research topics of 'Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically